164 related articles for article (PubMed ID: 8620446)
1. Effect of tamoxifen on intraperitoneal N-nitroso-N-methylurea induced tumors.
Martin G; Melito G; Rivera E; Levin E; Davio C; Cricco G; Andrade N; Caro R; Bergoc R
Cancer Lett; 1996 Feb; 100(1-2):227-34. PubMed ID: 8620446
[TBL] [Abstract][Full Text] [Related]
2. Hormone dependence of mammary tumors induced in rats by intraperitoneal NMU injection.
Martin G; Davio C; Rivera E; Melito G; Cricco G; Andrade N; Caro R; Bergoc R
Cancer Invest; 1997; 15(1):8-17. PubMed ID: 9028385
[TBL] [Abstract][Full Text] [Related]
3. Effect of tamoxifen on preneoplastic cell proliferation in N-nitroso-N-methylurea-induced mammary carcinogenesis.
Osborne MP; Ruperto JF; Crowe JP; Rosen PP; Telang NT
Cancer Res; 1992 Mar; 52(6):1477-80. PubMed ID: 1540955
[TBL] [Abstract][Full Text] [Related]
4. Antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model.
Gottardis MM; Jordan VC
Cancer Res; 1987 Aug; 47(15):4020-4. PubMed ID: 3607747
[TBL] [Abstract][Full Text] [Related]
5. Effects of tamoxifen and melatonin on mammary gland cancer induced by N-methyl-N-nitrosourea and by 7,12-dimethylbenz(a)anthracene, respectively, in female Sprague-Dawley rats.
Kubatka P; Bojková B; M ciková-Kalická K; Mníchová-Chamilová M; Adámeková E; Ahlers I; Ahlersová E; Cermáková M
Folia Biol (Praha); 2001; 47(1):5-10. PubMed ID: 11232869
[TBL] [Abstract][Full Text] [Related]
6. Combination of melatonin and tamoxifen as a chemoprophylaxis against N-nitroso-N-methylurea-induced rat mammary tumors.
Kothari A; Borges A; Ingle A; Kothari L
Cancer Lett; 1997 Jan; 111(1-2):59-66. PubMed ID: 9022128
[TBL] [Abstract][Full Text] [Related]
7. LAS, a novel selective estrogen receptor modulator with chemopreventive and therapeutic activity in the N-nitroso-N-methylurea-induced rat mammary tumor model.
Cohen LA; Pittman B; Wang CX; Aliaga C; Yu L; Moyer JD
Cancer Res; 2001 Dec; 61(24):8683-8. PubMed ID: 11751385
[TBL] [Abstract][Full Text] [Related]
8. Effect of glibenclamide on N-nitroso-N-methylurea-induced mammary tumors in diabetic and nondiabetic rats.
Cocca C; Martín G; Núñez M; Gutiérrez A; Cricco G; Mohamad N; Medina V; Croci M; Crescenti E; Rivera E; Bergoc R
Oncol Res; 2005; 15(6):301-11. PubMed ID: 16408695
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor profiles: changes in mouse and rat mammary tumors by treatment with selective estrogen receptor modifiers.
Actis AM; Cocca CM; Gutierrez A; Croci M; Rivera ES; Bergoc RM
Med Princ Pract; 2004; 13(4):220-6. PubMed ID: 15181328
[TBL] [Abstract][Full Text] [Related]
10. Effect of rosiglitazone on N-nitroso-N-methylurea-induced mammary tumors in rat.
Núñez M; Martín G; Cocca C; Mohamad N; Gutiérrez A; Cricco G; Medina V; Rivera E; Croci M; Crescenti E; Bergoc R
Anticancer Res; 2006; 26(3A):2113-22. PubMed ID: 16827153
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of N-nitroso-N-methylurea-induced rat mammary cancer by miso and tamoxifen, alone and in combination.
Gotoh T; Yamada K; Ito A; Yin H; Kataoka T; Dohi K
Jpn J Cancer Res; 1998 May; 89(5):487-95. PubMed ID: 9685851
[TBL] [Abstract][Full Text] [Related]
12. Induction of mammary tumors in rat by intraperitoneal injection of NMU: histopathology and estral cycle influence.
Rivera ES; Andrade N; Martin G; Melito G; Cricco G; Mohamad N; Davio C; Caro R; Bergoc RM
Cancer Lett; 1994 Nov; 86(2):223-8. PubMed ID: 7982211
[TBL] [Abstract][Full Text] [Related]
13. Influence of the estrous cycle during carcinogen exposure on nitrosomethylurea-induced rat mammary carcinoma.
Lindsey WF; Das Gupta TK; Beattie CW
Cancer Res; 1981 Oct; 41(10):3857-62. PubMed ID: 7197191
[TBL] [Abstract][Full Text] [Related]
14. N-nitroso-N-methylurea-induced mammary carcinogenesis: effect of prolactin on expression of Ia antigen by tumor cells.
Bernard DJ; Maurizis JC; Chassagne J; Chollet P; Plagne R
J Natl Cancer Inst; 1986 Jun; 76(6):1237-42. PubMed ID: 3012179
[TBL] [Abstract][Full Text] [Related]
15. [Effect of tamoxifen plus octreotide on DMBA-induced mammary tumors in rats].
Zeng XZ; Yao ZX
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):28-32. PubMed ID: 15808071
[TBL] [Abstract][Full Text] [Related]
16. N-nitroso-N-methylurea-induced mammary tumors in the rat: role of prolactin and a prolactin-lowering drug.
Gandilhon P; Mélançon R; Djiane J; Kelly PA
J Natl Cancer Inst; 1983 Jan; 70(1):105-9. PubMed ID: 6296514
[TBL] [Abstract][Full Text] [Related]
17. Correlation of tumour response with starting tumour size and dose of tamoxifen in an N-methyl-N-nitrosourea (NMU)-induced rat mammary cancer model.
Yankuzo HM; Emilia ST; Shaari R; Yaacob NS
Asian Pac J Cancer Prev; 2014; 15(16):6721-6. PubMed ID: 25169515
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen-induced antitumorigenic/antiestrogenic action synergized by a selective aryl hydrocarbon receptor modulator.
McDougal A; Wormke M; Calvin J; Safe S
Cancer Res; 2001 May; 61(10):3902-7. PubMed ID: 11358803
[TBL] [Abstract][Full Text] [Related]
19. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
[TBL] [Abstract][Full Text] [Related]
20. Characterization of new estrogen receptor destabilizing compounds: effects on estrogen-sensitive and tamoxifen-resistant breast cancer.
Hoffmann J; Bohlmann R; Heinrich N; Hofmeister H; Kroll J; Künzer H; Lichtner RB; Nishino Y; Parczyk K; Sauer G; Gieschen H; Ulbrich HF; Schneider MR
J Natl Cancer Inst; 2004 Feb; 96(3):210-8. PubMed ID: 14759988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
